skip to content
From alchemy to IPO : the business of biotechnology Preview this item
ClosePreview this item
  • Preview this Item (Questia)

From alchemy to IPO : the business of biotechnology

Author: Cynthia Robbins-Roth
Publisher: Cambridge, Mass. : Perseus, ©2000.
Edition/Format:   Book : EnglishView all editions and formats
Summary:
It is impossible to dispute the extraordinary impact biotechnology is having on our everyday lives. Companies such as Genentech, Immunex, Amgen and Biogen hold the technological and intellectual keys to controlling our genetic destiny and moving science to a new apex of breakthrough cures. Written by a well-known industry insider, this title addresses the coming-of-age of biotech products and companies and traces the  Read more...
Rating:

(not yet rated) 0 with reviews - Be the first.

 

Find a copy in the library

Retrieving... Finding libraries that hold this item...

Details

Document Type: Book
All Authors / Contributors: Cynthia Robbins-Roth
ISBN: 0738202533 9780738202532
OCLC Number: 44078478
Notes: Includes index.
Description: xv, 253 p. : ill. ; 24 cm.
Contents: Part 1 The Roots of Biotechnology --
Biotech in the Beginning --
Genentech: The Leader of the Pack --
The Amgen Story --
An Exception to Every Rule: Genzyme --
The Other Biotech: Monoclonal Antibodies --
Part 2 Biotechʼs Building Blocks --
Biotech Star Wars --
The Human Genome Project --
Tools for Genome Studies: BioChips and Microarrays --
Treating Disease at the Gene: Antisense Drugs --
Gene Therapy --
Following the Path of Communication: Signal Transduction --
Brand-New Knees: Tissue Engineering and Cell Replacement --
Building New Drugs: Combinatorial Chemistry --
Agricultural Biotechnology --
Part 3 The Business of Biotech: Product Development and Financing --
The Drug Development Process: From Test Tubes to Patients --
Speed Bumps and Brick Walls: Clinical Trial Design --
Biotech Bankers --
Initial Public Offerings --
Creative Financing --
Corporate Partners and the Urge to Merge --
Part 4 Biotech Stocks --
The Biotech Stock Landscape --
Picking the Right Stocks --
Appendix A Biotech Timeline --
Appendix B Biotechnology-Derived Products on the Market --
Appendix C Biotech Web Sites and Resources --
Appendix D BioVenture Consultantsʼ Biotech Stock Report.
Responsibility: Cynthia Robbins-Roth.

Abstract:

It is impossible to dispute the extraordinary impact biotechnology is having on our everyday lives. Companies such as Genentech, Immunex, Amgen and Biogen hold the technological and intellectual keys to controlling our genetic destiny and moving science to a new apex of breakthrough cures. Written by a well-known industry insider, this title addresses the coming-of-age of biotech products and companies and traces the history of biotechnology from its early inception in the ʼ70s to todayʼs heyday of new solutions and breakthrough treatments.

Reviews

User-contributed reviews
Retrieving weRead reviews...
Retrieving GoodReads reviews...
Retrieving Amazon reviews...

Tags

Be the first.
Confirm this request

You may have already requested this item. Please select Ok if you would like to proceed with this request anyway.

Close Window

Please sign in to WorldCat 

Don't have an account? You can easily create a free account.